Earlier this year, the company revealed early evidence that its booster jabs may be effective against ‘variants of concern’
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.